About Rakuten Medical
Rakuten Medical is a private company based in San Diego, California. It has reported $892,525,034 raised in 15 offerings on Form D since January 2015.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 16, 2026 | Oct 6, 2026 | $8,974,943fully sold | 14 | $641K | OptionsRule 506(b) | Form D ↗ |
| Jul 11, 2025 | Apr 13, 2026 | $111,522,289of $116.6M target | 26 | $4.2M | EquityRule 506(b) | Form D ↗ |
| Dec 12, 2024 | Feb 5, 2025amended May 7, 2025 | $1,865,406fully sold | 14 | $133K | Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Mar 13, 2024 | Mar 28, 2024 | $4,161,200fully sold | 15 | $277K | Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Aug 18, 2023 | Sep 1, 2023 | $104,816,348of $123.6M target | 15 | $6.9M | EquityRule 506(b) | Form D ↗ |
| Dec 16, 2022 | Dec 28, 2022 | $70,000,000of $90.0M target | 4 | $17.5M | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Jun 23, 2022 | Jul 7, 2022amended Oct 4, 2023 | $2,189,000fully sold | 20 | $109K | Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Jul 16, 2021 | Jul 29, 2021 | $166,010,712of $291.0M target | 10 | $16.6M | EquityRule 506(b) | Form D ↗ |
| Dec 23, 2020 | Jan 5, 2021 | $90,000,000fully sold | 6 | $15.0M | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Jul 31, 2019 | Aug 7, 2019 | $99,999,997fully sold | 1 | $99.9M | EquityRule 506(b) | Form D ↗ |
| Aug 10, 2018 | Aug 23, 2018amended Nov 7, 2018 | $149,999,993of $350.0M target | 4 | $37.4M | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| Jul 7, 2017 | Jul 21, 2017 | $15,079,974of $19.0M target | 45 | $335K | EquityRule 506(b) | Form D ↗ |
| Feb 24, 2016 | Mar 10, 2016amended Oct 5, 2016 | $55,199,998of $56.0M target | 8 | $6.8M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Jul 17, 2015 | Jul 30, 2015 | $4,249,999fully sold | 3 | $1.4M | EquityRule 506(b) | Form D ↗ |
| Dec 5, 2014 | Jan 23, 2015 | $8,455,175fully sold | 8 | $1.0M | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, 15 offerings | $892,525,034 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Rakuten Medical's Form D filed Oct 6, 2026.
Earlier filings also listed Mazen Darwazah (director, last listed Apr 2026), Kentaro Hyakuno (director, last listed Apr 2026), Carlos Garcia (executive officer, last listed Apr 2026), Takashi Toraishi (executive officer and director, last listed Mar 2024), Hiroshi Takasawa (director, last listed Mar 2024), Agatha Martindale (executive officer, last listed Mar 2024), Ann McGuire (executive officer, last listed Jul 2021) and Brenton Keath (chief financial officer, last listed Jan 2021).
Sources
- SECRakuten Medical, Inc. Form D, filed Feb 5, 2025
- SECRakuten Medical, Inc. Form D, filed Jul 7, 2022
- SECRakuten Medical, Inc. Form D/A, filed Nov 7, 2018
- SECRakuten Medical, Inc. Form D, filed Aug 23, 2018
- SECRakuten Medical, Inc. Form D, filed Mar 10, 2016
- SECRakuten Medical, Inc. filing history
- CompanyAbout Rakuten Medical
- CompanyLeadership